147 related articles for article (PubMed ID: 30758911)
21. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
Craythorne E; du Viver A; Mufti GJ; Warnakulasuriya S
J Oral Pathol Med; 2011 Sep; 40(8):616-20. PubMed ID: 21385212
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs.
Grando SA
Int J Dermatol; 2019 Jan; 58(1):114-125. PubMed ID: 30047585
[TBL] [Abstract][Full Text] [Related]
23. Emerging treatment options for the management of pemphigus vulgaris.
Kridin K
Ther Clin Risk Manag; 2018; 14():757-778. PubMed ID: 29740210
[TBL] [Abstract][Full Text] [Related]
24. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus.
Ioannou P; Tsagkaraki E; Vamvoukaki R; Kouvidou C; Krasagakis K; Chamilos G; Gikas A
Hellenic J Cardiol; 2019; 60(3):202-204. PubMed ID: 30092274
[No Abstract] [Full Text] [Related]
25. Treatment strategies for pemphigus vulgaris in Japan.
Hashimoto T
Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
[TBL] [Abstract][Full Text] [Related]
26. Herpes esophagitis in the setting of immunosuppression from pemphigus vulgaris therapy.
Kahn NH; Friedmann DP; Phillips CM
Cutis; 2015 Jan; 95(1):44-6. PubMed ID: 25671444
[TBL] [Abstract][Full Text] [Related]
27. [Combined immunosuppressive therapy in patients with pemphigus vulgaris and its side effects].
Vojácková N; Hejcmanová I; Schmiedbergerová R; Hercogová J
Cas Lek Cesk; 2005; 144(12):833-5. PubMed ID: 16389757
[TBL] [Abstract][Full Text] [Related]
28. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions.
Scully C; Paes De Almeida O; Porter SR; Gilkes JJ
Br J Dermatol; 1999 Jan; 140(1):84-9. PubMed ID: 10215773
[TBL] [Abstract][Full Text] [Related]
29. Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.
Bongiorno MR; Pistone G; Doukaki S; Aricò M
Int J Dermatol; 2010 Jun; 49(6):693-9. PubMed ID: 20618478
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
[TBL] [Abstract][Full Text] [Related]
31. Management of Pemphigus Vulgaris.
Cholera M; Chainani-Wu N
Adv Ther; 2016 Jun; 33(6):910-58. PubMed ID: 27287854
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
Doukaki S; Pistone G; Aricò M; Bongiorno MR
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
[TBL] [Abstract][Full Text] [Related]
33. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
[TBL] [Abstract][Full Text] [Related]
34. Pemphigus vulgaris: approach to treatment.
Sinha AA; Hoffman MB; Janicke EC
Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
[TBL] [Abstract][Full Text] [Related]
36. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
Porro AM; Hans Filho G; Santi CG
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
[TBL] [Abstract][Full Text] [Related]
37. Infective Endocarditis Involving the Pulmonary Valve.
Miranda WR; Connolly HM; DeSimone DC; Phillips SD; Wilson WR; Sohail MR; Steckelberg JM; Baddour LM
Am J Cardiol; 2015 Dec; 116(12):1928-31. PubMed ID: 26611123
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
Kong HH; Prose NS; Ware RE; Hall RP
Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
[TBL] [Abstract][Full Text] [Related]
39. Unusual presentation of cryolife O'Brien(R) stentless aortic valve bioprosthesis dysfunction mimicking infective endocarditis.
Lepage L; Krapf L; Hekimian G; Duval X; Nataf P; Hvass U; Vahanian A; Messika-Zeitoun D
Eur J Cardiothorac Surg; 2012 Apr; 41(4):800-5. PubMed ID: 22219468
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy.
Kanbay M; Selcuk H; Gur G; Yilmaz U; Boyacioglu S
J Natl Med Assoc; 2006 Aug; 98(8):1369-70. PubMed ID: 16916141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
